Arabinoxylan
Cereal hemicellulose fiber (and its AXOS oligosaccharides) with EFSA-backed postprandial glucose-lowering and a reliable bifidogenic effect.
What is Arabinoxylan?
Arabinoxylan (Cereal hemicellulose (AXOS)) is a prebiotic fiber used for lowers post-prandial blood glucose and insulin responses — the basis for an efsa-authorized health claim at ~8 g of wheat-endosperm ax-rich fiber per meal. NutriDex grades the human evidence as Moderate. Arabinoxylan (AX) is the main soluble hemicellulose fiber of cereal grains such as wheat, rye, barley and psyllium; enzymatically shortened forms are called arabinoxylan-oligosaccharides (AXOS). Its best-supported effect is on glucose: a 2025 systematic review and meta-analysis of clinical and preclinical studies found AX significantly reduced postprandial glucose and insulin responses, and the EFSA authorizes a health claim that ~8 g of AX-rich fiber from wheat endosperm per meal lowers post-prandial glycaemia. Small randomized crossover trials in people with type 2 diabetes or impaired glucose tolerance also show lower fasting glucose, HbA1c and triglycerides, and human studies consistently show AXOS is bifidogenic and raises short-chain fatty acids (especially butyrate). Evidence is most robust for acute glycemic and microbiome endpoints; data on LDL cholesterol, weight and long-term clinical outcomes are thinner and less consistent, with trials generally small.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Lowers postprandial glucose & insulin2025 meta-analysis (glucose iAUC SMD -0.41) and EFSA-authorized claim at ~8 g/meal; most robust AX endpoint. | Moderate | ↑ benefit · moderate | 3 |
| Improves longer-term glycemia (fasting glucose, HbA1c)Small crossover RCTs in T2D/IGT lowered fasting glucose, fructosamine, HbA1c; trials small (n=15) and few. | Preliminary | ↑ benefit · moderate | 2 |
| Prebiotic: bifidogenic, raises butyrate (AXOS)Multiple RCTs show AXOS raises fecal bifidobacteria/butyrate-producers and lowers p-cresol; well tolerated. | Moderate | ↑ benefit · moderate | 3 |
| Lowers fasting triglyceridesSmall crossover RCTs lowered triglycerides; LDL/total-cholesterol effects inconsistent and generally non-significant. | Preliminary | ↑ benefit · small | 2 |